Other than the share price being low, why are you dissatisfied? It seems like the company has a good plan. I'm annoyed that someone is unloading stock, but that alone doesn't make this a poor investment.
If you're on this board, you're one of 79. Maybe 78 now that we've seen all this selling.
Small number of investors here.
1.50, 1.60, 1.70... who cares exactly where you get it when it's 4.00 or 8 dollars. I wouldn't be trying to make an extra 10 cents off the price.
Next is to announce that the sensor is improved, more likely to get approval. Uptick in the stock price to 5 dollars and then they can sell some more shares to float them for the next year or two. I'm happy to see platinum financing them and i hate to think of more dilution, but i want this company to have at least 2 years of future.
It looks to me like the selling that has been driving this down has stopped. Now we're seeing buyers step in and take this up a few cents each day. I'm pretty optimistic.
those are acquired shares based on exercising the options. I don't see him disposing of the options or shares.
I have to agree at this point, I've come to appreciate just how important it is that the management is communicative and shareholder friendly.
As long as Platinum keeps on floating the company money and return for options that are above the current share price, then I'll stay invested. Platinum was getting call options with a strike of 3, so I'm pretty certain they will keep on giving echo money to get by as long as the price is under 3. That's nearly a double from here.
Yeah I recall that MTIA is going to pick up the tab for all chinese trials, and they get 70% of revenue until revenue becomes huge, when MTIA then only gets 60% revenue.
It fell on 10k shares. How does the management's opinion in the company translate into a one day stock gain/loss? They didn't sell any shares and they didn't put any announcement out.
no one knows that a company is going to be bought until the last second. How do you know there aren't ongoing discussions?
Plus why would pharma buy a company making a medical device? Pharma is buying cancer drugs.
When PWC was retained, the company was at 0.60 per shares, valuing it at like 8 million dollars. I'm sure that they could have found a buyer then for 20 or 30 million, but virtually every investor would be underwater on an asset that is valued by these investors as 100 million. So it's better to right the sinking ship, demonstrate progress and pull the value of the company up to 50 million and then sell it for several fold higher.
Isn't the adjusted price of the initial IPO shares 40 dollars after you back out the reverse splits? I think that most investors would want to be made whole, so would hold out for that price rather than just take what they can. If I bought in any of the offerings, I'd want to sell to recoup what i had invested.
Or not. They just lend the shares out to short sellers who pay approximately 7% annually to short (current rate for kerx). Then they buy the shares back from the shorts and lend them out to the shorts again. No need to waste resources shorting against the box. You claim "make money in both directions" which really is "make money in no direction, but tie up resources"
I'm guessing they have to lose... 800 million dollars by doing that. Right now they have only 200 million at risk.